Aboleris Pharma
BelgiumWho owns Aboleris Pharma?
Aboleris Pharma is a Belgian Biotech company, now owned by A.L.M. MANAGEMENT & CONSULTING, which acquired it in 2024 from Turenne Groupe.
Caixa Capital Risc is still listed as an investor in Aboleris Pharma, status not confirmed after the 2024 sale.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods · co-invest detected
Turenne Groupe sold ABOLERIS PHARMA to A.L.M. MANAGEMENT & CONSULTING in 2024 after 4 years.
More from Criteria Bio Ventures
Other portfolio companies in the same fund.
UK
Spain
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Aboleris Pharma?
Aboleris Pharma is now owned by A.L.M. MANAGEMENT & CONSULTING, which acquired it in 2024 from Turenne Groupe. Caixa Capital Risc is still listed as an investor in Aboleris Pharma, status not confirmed after the 2024 sale.
When did A.L.M. MANAGEMENT & CONSULTING acquire Aboleris Pharma?
A.L.M. MANAGEMENT & CONSULTING acquired Aboleris Pharma in 2024, buying from Turenne Groupe.
Who did Aboleris Pharma sell to?
Turenne Groupe sold Aboleris Pharma to A.L.M. MANAGEMENT & CONSULTING in 2024 (Secondary).
Who has owned Aboleris Pharma over time?
Aboleris Pharma has been through 2 private-equity ownership periods: Turenne Groupe · via Capital Santé 2 · 2020–2024 · sold to A.L.M. MANAGEMENT & CONSULTING · (Secondary); Caixa Capital Risc · via Criteria Bio Ventures · since 2023.